Medtronic Hopes For Speedy U.S. Launch Of Revo MRI-Friendly Pacer
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is hoping to receive FDA approval of its Revo MRI SureScan MRI-safe pacemaker and launch it in the U.S. within six months now that the device has received a unanimous approval recommendation from an FDA advisory panel